Business Wire

Concacaf Debuts Enhanced Digital Platform and Mobile App in Partnership with Deltatre

13.5.2026 14:17:00 CEST | Business Wire | Press Release

Share

Concacaf today announced the launch of a new website and mobile app experience deployed using Deltatre's award-winning technology, establishing a single digital destination for football fans across the confederation's 41 Member Associations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513938978/en/

Concacaf.com and the mobile app, available now on iOS and Android, bring together live streaming, video-on-demand, real-time match data, full match stats, player and team profiles, and personalized content in one platform, marking a significant step forward in how Concacaf connects with fans.

The platform organizes the confederation's men's, women's, and club tournaments for quick access, with full multi-language support in English and Spanish.

Fans can create a free account for immediate personalization, allowing them to follow their favorite national teams, competitions, and clubs. Granular notifications are also available for key match events, news and highlights; plus a "Where to Watch" feature that surfaces live matches and broadcaster information for enhanced discoverability.

The Concacaf platform is powered by Deltatre FORGE, the same technology supporting the digital properties of the NFL, NHL, MLB, MLS, NWSL, Serie A, CPL, and more than 300 major sports federations, leagues, teams and clubs.

“This launch is an important step in how we bring Concacaf football closer to fans across our region,” said Philippe Moggio, Concacaf General Secretary. “Our new website and app are designed to make it easier for supporters to follow the competitions, teams, players, and moments that matter most to them, while giving us a stronger foundation to keep improving the digital experience over time.”

"The flexibility of the ecosystem we’ve built gives Concacaf and its stakeholders the foundation to evolve quickly, introduce new experiences, and unlock greater value from its content and fan relationships over time," said Peter Bellamy, CRO at Deltatre. "This is a world-class destination that will continue to build a deep sense of loyalty with supporters in the Americas and beyond."

The platform has been built around the needs of fans in different viewing contexts. In markets where broadcast coverage exists, Concacaf.com and the app function as a seamless second-screen companion, enriching the viewing experience with real-time insights and complementary content. In regions without broadcast access, the platform acts as the primary destination for live match coverage.

The ecosystem integrates advanced advertising and sponsorship tools, SEO optimization, a comprehensive analytics framework, and a unified single-customer view which enables precise fan segmentation and personalization at scale.

Visit the website

https://www.concacaf.com

Download the App

Apple App Store: https://apps.apple.com/us/app/concacaf-official/id6746340036

Google Play: https://play.google.com/store/apps/details?id=com.concacaf.app

About Concacaf

The Confederation of North, Central America, and Caribbean Association Football (Concacaf) is one of FIFA’s six continental confederations, servicing 41 Member Associations, from Canada in the north to Guyana, Suriname, and French Guiana in the south. Concacaf means football first. Our members are united by a shared vision: Love For Our Game, as well as a unique mission, to develop, promote and manage football throughout the region with integrity, transparency, and passion in order to inspire participation in the game.

About Deltatre

Over four decades, Deltatre has built the trust of many of the world’s biggest broadcasters, telcos, sports teams, leagues, federations, and governing bodies. Driven to create the digital experiences of tomorrow, it stands as the only partner uniting OTT and digital platforms, with data, graphics, officiating, and strategy and growth services. Clients include the NFL, UFC, Sky, Rogers, DFB, NBA, WWE, MLB, Concacaf, MLS, BBC, Bell Media, ATP, Serie A, ICC, World Rugby, and UEFA. https://deltatre.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20260513938978/en/

Contacts

press@deltatre.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press Release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press Release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press Release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye